White Paper: Emerging Specialty Strategies

Specialty drug costs are growing at an unsustainable pace and increasingly pose a financial threat to the entire health care benefit. Traditional PBM solutions are not well equipped to tackle this problem for plan sponsors. This insightful white paper provides an overview of alternative models for managing specialty drugs and key considerations for each.